Ultralife Q2 EPS $0.15 vs $0.05; record backlog $117.5M, gross margin up 500 bps

ULTRALIFE CORP

2026-Q2 EPS reported $13.00 revenue$95,388,000

Sales $47.9M, down 1.3% YoY; gross margin 28.9% vs 23.9% (incl. $1.1M IEEPA refund).
GAAP EPS $0.15 vs $0.05; adjusted EBITDA $6.1M vs $4.1M.
Backlog $117.5M, record high, up from $115.1M Q1 and $84.5M year ago.
Communications Systems sales up 39.3% to $3.8M; Battery & Energy down 3.7% to $44.2M.
One-time costs $0.9M (litigation for cyber-insurance claim, consulting); 45X tax credit partially offsets interest.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.